JP2004520264A5 - - Google Patents

Download PDF

Info

Publication number
JP2004520264A5
JP2004520264A5 JP2002515293A JP2002515293A JP2004520264A5 JP 2004520264 A5 JP2004520264 A5 JP 2004520264A5 JP 2002515293 A JP2002515293 A JP 2002515293A JP 2002515293 A JP2002515293 A JP 2002515293A JP 2004520264 A5 JP2004520264 A5 JP 2004520264A5
Authority
JP
Japan
Prior art keywords
complexed
composition
iron
methemoglobin
supplements
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002515293A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004520264A (ja
Filing date
Publication date
Priority claimed from FR0009883A external-priority patent/FR2812200B1/fr
Application filed filed Critical
Publication of JP2004520264A publication Critical patent/JP2004520264A/ja
Publication of JP2004520264A5 publication Critical patent/JP2004520264A5/ja
Pending legal-status Critical Current

Links

JP2002515293A 2000-07-27 2001-07-27 鉄錯化蛋白質および一酸化窒素代謝の前駆体および／または一酸化窒素の化学的ドナーを含有する組成物ならびにその使用 Pending JP2004520264A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0009883A FR2812200B1 (fr) 2000-07-27 2000-07-27 Composition contenant une proteine complexant le fer et un precurseur du metabolisme du monoxyde d'azote et/ou un donneur chimique de monoxyde d'azote ; et utilisations
PCT/FR2001/002469 WO2002009740A1 (fr) 2000-07-27 2001-07-27 Composition contenant une proteine complexant le fer et un precurseur du metabolisme du monoxyde d'azote et/ou un donneur chimique de monoxyde d'azote et utilisations

Publications (2)

Publication Number Publication Date
JP2004520264A JP2004520264A (ja) 2004-07-08
JP2004520264A5 true JP2004520264A5 (https=) 2005-03-03

Family

ID=8852998

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002515293A Pending JP2004520264A (ja) 2000-07-27 2001-07-27 鉄錯化蛋白質および一酸化窒素代謝の前駆体および／または一酸化窒素の化学的ドナーを含有する組成物ならびにその使用

Country Status (8)

Country Link
US (1) US6984624B2 (https=)
EP (1) EP1303296B1 (https=)
JP (1) JP2004520264A (https=)
AT (1) ATE292978T1 (https=)
AU (1) AU2001279922A1 (https=)
DE (1) DE60110084D1 (https=)
FR (1) FR2812200B1 (https=)
WO (1) WO2002009740A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10215315A1 (de) * 2002-04-05 2003-11-20 Aventis Behring Gmbh Intellect Human-Transferrin zur Behandlung der Anaemia of Chronic Disease (ACD) und des funktionellen Eisenmangels
EP1675501B1 (en) 2003-09-12 2013-09-04 Or-Nim Medical Ltd. Noninvasive optical monitoring of region of interest
EP1589283B1 (en) * 2004-04-23 2006-08-16 Abb Research Ltd. Model and control of a waste combustion process
ZA200702421B (en) * 2004-10-08 2008-09-25 Unilever Plc Iron complex for use in the treatment and/or prevention of nutritional disorders
EP1867330A4 (en) * 2005-03-30 2012-01-25 Kyowa Hakko Bio Co Ltd METHOD FOR IMPROVING THE STORAGE STABILITY OF A SUBSTANCE
US20090202613A1 (en) * 2008-02-11 2009-08-13 Tabatchnick Fine Foods, Inc. Nutritionally Enhanced Therapeutic Preventative Food Supplement and Method of Making Same
WO2009101789A1 (ja) * 2008-02-14 2009-08-20 Morinaga Milk Industry Co., Ltd. 卵巣機能改善剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE192922T1 (de) * 1993-11-02 2000-06-15 Us Health Verwendung von stickstoffoxid freisetzenden verbindungen zur herstellung eines arzneimittels zum schutz gegen die ischämischen reperfusionsschäden
US5827729A (en) * 1996-04-23 1998-10-27 Advanced Tissue Sciences Diffusion gradient bioreactor and extracorporeal liver device using a three-dimensional liver tissue
US6333311B1 (en) * 1997-02-03 2001-12-25 Pharming Useful properties of human lactoferrin and variants thereof

Similar Documents

Publication Publication Date Title
WO2003092624A3 (en) Use of heat shock proteins to enhance efficacy of antibody therapeutics
JPH11315838A5 (https=)
WO2004017998A3 (en) Topical emulsion- gel composition comprising diclofenac sodium
JP2004520264A5 (https=)
HUP0304085A2 (en) The citrate salt of 5,8,14-triazatetracyclo(10.3.1.02,11.04.9)-hexadeca-2.(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
WO2007044180A3 (en) Improved toleration iron supplement compositions
WO1999011256A8 (en) L-threonate ferrous, as well as pharmaceutical composition and use for improving and treating human anemia thereof
MY136877A (en) Dietary supplementation with stoichiometrically specific potassium magnesium citrate
ATE476195T1 (de) Zubereitungen von pro-insulin-c-peptid mit verzögerter freisetzung
ATE287716T1 (de) Metallsalze als antimykotika
JP2006193428A5 (https=)
RU2001102729A (ru) Формовочный состав для декоративных изделий
RU2001102346A (ru) Обогащающая добавка для производства различных видов молока
RU2002109338A (ru) Композиция для окрашивания пищевых продуктов
RU2001115949A (ru) Комплексная добавка
JP2000044842A5 (https=)
RU2001131915A (ru) Биологически активная пищевая добавка
RU2002124461A (ru) Композиция травяного чая
RU2003123568A (ru) Пищевой хелатный комплекс
RU2006111878A (ru) Ковкий чугун
RU2001135112A (ru) Литейный алюминиевый сплав
HN2002000112A (es) Sal citrato de 5, 8,14 - triazatetraciclo [10.3.1.02.11.04.9] - hexadeca - 2 (11),3,5,7,9 - pentaeno y composiciones farmaceuticas de la misma.
TH81335B (th) โคมไฟ
TH92989B (th) ขอแขวนผ้า
RU2006130173A (ru) Сплав на основе марганца